Results 41 to 50 of about 23,513 (225)

Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis

open access: yesJournal of Translational Autoimmunity, 2023
Introduction: Rituximab monotherapy represents the main therapeutic option for cryoglobulinemic vasculitis (CV) with severe organ involvement. However, initial worsening of the CV, known as rituximab-associated CV flare (=CV flare), has been described ...
Léa Fornero   +9 more
doaj   +1 more source

Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation

open access: yesKidney Research and Clinical Practice, 2017
Background: Plasmapheresis has become an essential element of kidney transplantation (KT). In the present study, we report clinical outcomes of filtration plasmapheresis using continuous renal replacement therapy machines with a single filter for the ...
Eunsoo Lim   +7 more
doaj   +1 more source

The Use of Plasmapheresis in Treatment of Patients with Infertility, Peritoneal Endometriosis and Nat2 Gene Polymorphism [PDF]

open access: yes, 2016
It is known that 30–40 % of patients with peritoneal endometriosis suffer from infertility. Half of the patients with endometriosis are identified point mutation in NAT2 – gene, which plays an important role in the acetylation of aromatic and ...
Dubinskaya, E. (Ekaterina)   +2 more
core   +2 more sources

Bone density and bone metabolism in plasmapheresis donors

open access: yesZhongguo shuxue zazhi
Objective To investigate the level of serum bone metabolism and biochemical markers and bone density of plasmapheresis donors, and to provide scientific basis for ensuring the health and safety of plasmapheresis donors in China.
Wan LI   +5 more
doaj   +1 more source

The 1(st) and the 2(nd) Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and update [PDF]

open access: yes, 2016
The clinical indications and guidelines for low-density lipoprotein (LDL)-apheresis set by the 1(st) Italian Consensus Conference held in Ostuni in 1990 and completed in 1992, but never published, are reported schematically.
Stefanutti, Claudia
core   +1 more source

Application of biological age assessment of Chinese population in potential anti-ageing technology

open access: yesImmunity & Ageing, 2018
Background This study aimed to construct a biological age assessment formula for the Chinese population and to explore the effectiveness of double filtration plasmapheresis for anti-ageing and longevity. Methods 915 subjects were recruited, including 584
Xufeng Li   +7 more
doaj   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature

open access: yesTherapeutic Advances in Endocrinology and Metabolism, 2017
Background: Severe hypertriglyceridemia (HTG) is the third leading cause of acute pancreatitis (AP) in the United States. The current standard of care includes management of HTG using pharmacological therapy.
Kiran Joglekar   +3 more
doaj   +1 more source

Dataset concerning haematological and biochemical parameters changes in show jumping horses subjected to exercise and plasmapheresis session

open access: yesData in Brief, 2019
This article presents data on the effect of plasmapheresis on clinical, haematological and biochemical parameters in horses following exercise and after a plasmapheresis session.
Réda Daden   +7 more
doaj   +1 more source

The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients

open access: yesHeliyon, 2022
Background: There is no definitive treatment for COVID-19. Hemoperfusion and plasmapheresis have only been studied in a few cases of COVID-19. In this study, plasmapheresis-hemoperfusion and current treatment for COVID-19 patients were compared for ...
Seyede Mahboobeh Raoofi Kelachayeh   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy